Notice of Clarification to Information Regarding Application Due Dates for PAR-13-146 NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)

Notice Number: NOT-CA-14-052

Key Dates
Release Date: August 4, 2014

Related Announcements
PAR-13-146

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to clarify information regarding the Application Due Dates for PAR-13-146 "NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)".

Part 1. Key Dates

The FOA currently reads:

Application Due Date(s)

June 28, 2013; (Extended to November 1, 2013 per NOT-OD-14-003), Originally October 28, 2013; February 28, 2014; June 27, 2014; October 28, 2014; February 27, 2015; June 29, 2015, by 5:00 PM local time of applicant organization.

AIDS Application Due Date(s)

September 5, 2013; January 6, 2014; May 5, 2014; September 5, 2014; January 5, 2015; May 5, 2015; September 4, 2015, by 5:00 PM local time of applicant organization.

The FOA is modified to read:

Application Due Date(s)

June 28, 2013; (Extended to November 1, 2013 per NOT-OD-14-003), Originally October 28, 2013; February 28, 2014; June 27, 2014; October 28, 2014; February 27, 2015; June 29, 2015, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

September 5, 2013; January 6, 2014; May 5, 2014; September 5, 2014; January 5, 2015; May 5, 2015; September 4, 2015, by 5:00 PM local time of applicant organization. All types of AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Referral Officer
National Cancer Institute
Telephone: 240-276-6390
Email: [email protected]